arrow
F

Fabrice Antigny

Hôpital Marie Lannelongue
H指数:37
被引数:4,396

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination of Orai1 inhibitor CM5480 with specific therapy mitigates pulmonary hypertension and its cardiac dysfunction

Orai1抑制剂CM5480与特异性疗法的联合应用减轻了肺动脉高压及其心脏功能障碍

2025-11-101
PRE
Evolving paradigms in pulmonary hypertension: Highlights of the 6th French Pulmonary Hypertension Network Meeting

肺动脉高压的发展范式: 第六届法国肺动脉高压网络会议的亮点

2025-10-010
OAAI
Role of KCNK3 Dysfunction in Dasatinib-associated Pulmonary Arterial Hypertension and Endothelial Cell Dysfunction

KCNK3功能障碍在达沙替尼相关肺动脉高压和内皮细胞功能障碍中的作用

2024-07-012
PRE
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors

与蛋白酶体抑制剂相关的肺动脉高压患者的特征和预后

2024-05-021
PRE
Monocyte-derived Extracellular Delta-like 4 Contributes To Pulmonary Hypertension Progression By Inhibiting Endothelial Notch1 Activation

单核细胞衍生的细胞外Delta样4通过抑制内皮细胞Notch1活化促进肺动脉高压进展

2024-05-010
PRE
Pulmonary vascular phenotype identified in patients with GDF2 (BMP9) or BMP10 variants: an international multicentre study

GDF2 (BMP9) 或BMP10变异患者的肺血管表型: 一项国际多中心研究

2024-03-214
PRE
Late Breaking Abstract - Involvement of Orai1 Ca2+channel in the pathogenesis of pulmonary arterial hypertension. Orai1 as a new potential therapeutic target ?
2021-11-250
PRE